PD Dr. med. Manuel Meyer | Prof. Dr. med. Adam Czaplinski | Tel. +41 44 295 30 45
Prof. Dr. med. Adrian M. Siegel | Tel. +41 44 295 30 30
Theaterstrasse 8, 8001 Zürich | www.neurozentrumbellevue.ch
Prof. Dr. med. Adam Czaplinski – Kongressvorträge & Präsentationen
Oral laquinimod for Multiple Sclerosis.
TEVA Symposium, Mai 2010
Jerusalem/Israel
The effect of IFNbeta 1b treatment on cognition in Multiple Sclerosis.
Advisory Board meeting, March 2010
Rome/Italy
Treatment failure, what to do?
Multiple Sclerosis State of the Art, Januar 2010
Luzern/Switzerland
Safety overview of fingolimod.
Fingolimod Advisory Board, December 2009
Berlin/Germany
New oral agents in the therapy of Multiple Sclerosis.
Cladribine Advisory Board, November 2009
Amsterdam/Netherlands
Phasenadaptierte Therapie der Multiplen Sklerose.
182. Tagung der Schweizerischen Neurologischen Gesellschaft, Juni 2009
Interlaken/Switzerland
Application of the Database Controls in Experimental Trials.
Annual Meeting of St.Lukes Hospital, April 2009
Tokyo/Japan
ALS: Can We Predict the Course of Disease?
19. Kongress des Wissenschaftlichen Beirates der DGM, March 2009
Darmstadt/Germany
Natalizumab in daily practice- risks and benefits.
11th State of the Art Symposium, January 2009
Berne/Switzerland
Strategien zur Optimierung der immunomudulatorischen Therapie der MS.
Zürcher MS-Roundtable, Oktober 2008
Zurich/Switzerland
Moderne Therapie der Multiplen Sklerose
Quadrimed Kongress, Mai 2008
Crans Montana/Switzerland
Reconsidering clinical outcomes: relapses, impairment, disability and beyond.
Symposium of the European Charcot Foundation, November 2007
Fiuggi/Italy
Length of prediagnostic period as a predictor of rate of disease progression and survival in ALS.
17th Meeting of the European Neurological Societ, June 2007
Rhodes/Greece
Slower disease progression and prolonged survival in contemporary ALS patients: is the natural history of ALS changing?
177. Tagung der Schweizerischen Neurologischen Gesellschaft, Oktober 2006
Interlaken/Switzerland
Amyotrophic Lateral Sclerosis: Can We Predict the Course of Disease?
Kongress der Polnischen Neurologischen Gesellschaft, September 2006
Krakow/Poland
Predictability of disease progression in amyotrophic lateral sclerosis.
XVIth Meeting of the European Neurological Society, Mai 2006
Lausanne/Switzerland
Slower disease progression and prolonged survival in contemporary ALS patients: is the natural history of ALS changing?
58th Annual Meeting of American Academy of Neurology, April 2006
San Diego/USA
Predictability of disease progression in amyotrophic lateral sclerosis.
16th International Symposium on ALS/MND, December 2005
Dublin/Ireland
Amyotrophic lateral sclerosis: early predictors of prolonged survival.
World Congress of Neurology, November 2005
Sydney/Australia
Application of the Database Controls in Experimental Trials for Amyotrophic Lateral Sclerosis.
57th Annual Meeting of American Academy of Neurology, April 2005
Miami/USA
Flail arm syndrome: a clinical variant of amyotrophic lateral sclerosis.
XIIIth Meeting of the European Neurological Society, June 2003
Istanbul/Turkey
Pathological crying as the initial presenting symptom in amyotrophic lateral sclerosis.
XIIIth Meeting of the European Neurological Society, June 2003
Istanbul/Turkey
Symptomatic care in ALS
Basler ALS Symposium, March 2003
Basel/Switzerland
Predictive value of T2-lesion volume for the natural course of multiple sclerosis.
Meeting of the Polish Neurological Society, September 200
Poznan/Poland
Rapid progressive, sensory-motor demyelinating neuropathy.
Xth International Neuromuscular Congress, July 2002
Vancouver/Canada
Ice pack test for myasthenia gravis: a simple, noninvasive and safe diagnostic method.
Xth International Neuromuscular Congress, July 2002
Vancouver/Canada
The natural course of multiple sclerosis: predictive value of lesion volume in T2-weighted brain MRI.
XIIth Meeting of the European Neurological Society, June 2002
Berlin/Germany
Necrotising vasculitis and isotretinoin.
XIIth Meeting of the European Neurological Society, June 2002
Berlin/Germany
Diese Seite drucken
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |